Unit Converter
Digitoxin

SI UNITS (recommended)

CONVENTIONAL UNITS

(Cardiac Glycoside – Therapeutic Drug Monitoring for Heart Failure & Arrhythmias)

Synonyms

  • Digitoxin
  • Digitalis toxin
  • Cardiac glycoside (digitoxin type)
  • Cardioactive steroid
  • Gitoxin (older name)

Units of Measurement

  • nmol/L
  • µg/L
  • µg/dL
  • µg/100 mL
  • µg%
  • ng/mL

1 ng/mL = 1 µg/L
1 µg/dL = 0.01 µg/mL = 10 ng/mL
µg/100 mL = µg% = µg/dL
1 nmol/L = 0.764 ng/mL (using MW = 764.9 g/mol)

Description

Digitoxin is a cardiac glycoside derived from Digitalis purpurea (foxglove).
It increases cardiac contractility and decreases heart rate through:

  • Inhibition of Na⁺/K⁺-ATPase → ↑ intracellular Ca²⁺
  • Enhanced vagal tone → slowing of AV conduction

Digitoxin is used for:

  • Congestive heart failure (historically)
  • Supraventricular arrhythmias (especially atrial fibrillation)

Although digoxin is more commonly used today, digitoxin remains clinically relevant in certain regions and populations.

Digitoxin has:

  • Longer half-life (5-7 days)
  • Higher protein binding
  • Hepatic metabolism
    This makes it suitable for patients with renal insufficiency, unlike digoxin.

Physiological Role

Digitoxin has no physiological role; it is purely pharmacologic.

Mechanism:

  1. Blocks Na⁺/K⁺ ATPase
  2. Increases intracellular Na⁺
  3. Reduces Na⁺/Ca²⁺ exchange
  4. Increases intracellular Ca²⁺ storage in sarcoplasmic reticulum
  5. Enhances cardiac contractility (positive inotropy)

Clinical Significance

Elevated Digitoxin (Toxicity)

Digitoxin has a narrow therapeutic index.

Symptoms of Toxicity

Cardiac:

  • PVCs
  • AV block
  • Bradycardia
  • Ventricular tachycardia/fibrillation

Gastrointestinal:

  • Nausea, vomiting
  • Anorexia
  • Abdominal pain

Neurologic:

  • Confusion
  • Delirium
  • Visual disturbances (yellow/green halos)

Electrolytes:

  • Hypokalemia → increases toxicity
  • Hypercalcemia → increases toxicity
  • Hypomagnesemia → increases toxicity

Digitoxin toxicity is life-threatening.

Low Digitoxin

  • Subtherapeutic dosing
  • Poor adherence
  • Drug interactions that reduce absorption
  • Malabsorption

Low levels reduce treatment efficacy.

Reference Intervals (Therapeutic Ranges)

(Tietz 8E + Cardiac Pharmacology + Mayo + ARUP)

Therapeutic Range

  • 10 – 30 ng/mL (≈ 13–39 nmol/L)
  • Optimal target: 15–25 ng/mL

Toxic Level

  • > 35 ng/mL (≈ >46 nmol/L)
    Levels correlate poorly with serum concentration in acute toxicity - interpret clinically.

Diagnostic Uses

1. Therapeutic Drug Monitoring

Digitoxin levels are measured to:

  • Maintain safe therapeutic range
  • Prevent toxicity
  • Adjust dose in hepatic impairment
  • Adjust dose in elderly

2. Assessing Toxicity

Indicated when:

  • Arrhythmias
  • GI symptoms
  • Altered sensorium
  • Electrolyte abnormalities
  • Drug interactions (quinidine, verapamil, amiodarone)

3. Renal Impairment

Digitoxin preferred over digoxin due to:

  • Hepatic metabolism
  • Minimal renal excretion
    Hence levels needed for dose titration.

4. Drug Interactions

Digitoxin levels increase with:

  • Amiodarone
  • Verapamil
  • Quinidine
  • Macrolides
  • Azoles
  • Tamoxifen

Levels decrease with:

  • Rifampicin
  • Phenytoin

Analytical Notes

  • Serum samples preferred
  • Collect 6–8 hours after last dose (trough)
  • High protein binding → free digitoxin levels rarely measured
  • Immunoassays commonly used
  • Hemolysis minimal effect
  • Monitor electrolytes, especially K⁺, Mg²⁺, Ca²⁺

Clinical Pearls

  • Digitoxin is safer than digoxin in renal failure, but more dangerous in hepatic disease.
  • Hypokalemia significantly increases digitoxin toxicity - always check potassium.
  • ECG is often more sensitive for toxicity signs than serum levels.
  • Digitoxin has a long half-life → toxicity develops slowly but also resolves slowly.
  • Treatment of toxicity includes:
    • Digoxin immune Fab (cross-reacts with digitoxin)
    • Correct electrolytes
    • Supportive care

Interesting Fact

Digitoxin and digoxin originate from the foxglove plant (Digitalis), discovered in 1785 by William Withering - one of the oldest drugs still in modern medicine.

References

  1. Tietz Clinical Chemistry & Molecular Diagnostics, 8th Edition - Therapeutic Drug Monitoring.
  2. Cardiac Pharmacology Texts - Digitalis Glycosides.
  3. AHA/ACC Guidelines - Heart Failure & Arrhythmias.
  4. Mayo Clinic Laboratories - Digitoxin.
  5. ARUP Consult - Digitalis Toxicity.
  6. MedlinePlus / NIH - Digitalis Drugs.

Last updated: January 26, 2026

Reviewed by : Medical Review Board

Change language

Other Convertors